tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:0MGB Stock Latest News

Genmab: Overvalued Amid Earnings Pressure, Dilutive Merus Deal, and Rising Patent‑Cliff Risks
RatingsGenmab: Overvalued Amid Earnings Pressure, Dilutive Merus Deal, and Rising Patent‑Cliff Risks
4d ago
GMAB
Genmab price target lowered to $40 from $45 at Guggenheim
PremiumThe Fly
Genmab price target lowered to $40 from $45 at Guggenheim
4d ago
GMAB
Genmab: Solid Royalties and Strategic Deals, But 2026 Data Risks Justify Maintaining a Hold at $32 Target
PremiumRatings
Genmab: Solid Royalties and Strategic Deals, But 2026 Data Risks Justify Maintaining a Hold at $32 Target
9d ago
GMAB
Buy Rating Backed by 2026 Oncology Catalysts and Margin Outperformance Driving 40%+ Mid-Term EPS Upside
PremiumRatings
Buy Rating Backed by 2026 Oncology Catalysts and Margin Outperformance Driving 40%+ Mid-Term EPS Upside
9d ago
GMAB
Genmab price target raised to $40 from $39 at H.C. Wainwright
PremiumThe Fly
Genmab price target raised to $40 from $39 at H.C. Wainwright
9d ago
GMAB
Genmab: Near-Term Guidance Miss Offset by Strong Results and Blockbuster Late-Stage Pipeline Upside
PremiumRatingsGenmab: Near-Term Guidance Miss Offset by Strong Results and Blockbuster Late-Stage Pipeline Upside
10d ago
GMAB
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
Premium
The Fly
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
10d ago
JNJ
GMAB
Genmab resumed with a Buy at Jefferies
Premium
The Fly
Genmab resumed with a Buy at Jefferies
11d ago
GMAB
Genmab: De-Risked Long-Term Profile and 2026 Clinical Catalysts Support Buy Rating and DKK 2,650 Target
PremiumRatings
Genmab: De-Risked Long-Term Profile and 2026 Clinical Catalysts Support Buy Rating and DKK 2,650 Target
11d ago
GMAB
Genmab: Early-Stage Transition to Fully Integrated Biotech Warrants Balanced ‘Hold’ Amid 2026 Data Catalysts and Execution Risks
PremiumRatings
Genmab: Early-Stage Transition to Fully Integrated Biotech Warrants Balanced ‘Hold’ Amid 2026 Data Catalysts and Execution Risks
11d ago
GMAB
Genmab resumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Genmab resumed with an Equal Weight at Morgan Stanley
11d ago
GMAB
0MGB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
0MGB Upcoming Earnings Report: What to Expect?
25d ago
AI Daily: Nvidia invests $2B in CoreWeave
PremiumThe FlyAI Daily: Nvidia invests $2B in CoreWeave
1M ago
LLY
NVS
Drugmakers use AI to help progress through trials, submissions, Reuters says
Premium
The Fly
Drugmakers use AI to help progress through trials, submissions, Reuters says
1M ago
GSK
LLY
Genmab reports worldwide net sales of Darzalex in 2025 totaled $14.351B
Premium
The Fly
Genmab reports worldwide net sales of Darzalex in 2025 totaled $14.351B
1M ago
JNJ
GMAB
Genmab: Diversified Oncology Pipeline Supports Upside and Maintained Buy Rating Despite EPKINLY Phase 3 Setback
PremiumRatings
Genmab: Diversified Oncology Pipeline Supports Upside and Maintained Buy Rating Despite EPKINLY Phase 3 Setback
1M ago
GMAB
Genmab price target lowered to $39 from $41 at H.C. Wainwright
PremiumThe Fly
Genmab price target lowered to $39 from $41 at H.C. Wainwright
1M ago
GMAB
Genmab price target raised to $38.50 from $34.70 at BofA
PremiumThe Fly
Genmab price target raised to $38.50 from $34.70 at BofA
1M ago
GMAB
Maintaining Buy on Genmab: Epkinly Combination Potential Outweighs Monotherapy Setback
PremiumRatings
Maintaining Buy on Genmab: Epkinly Combination Potential Outweighs Monotherapy Setback
1M ago
GMAB
Genmab: Limited Epkinly Approval Risk and High-Value 2026 Pipeline Catalysts Support Buy Rating
PremiumRatingsGenmab: Limited Epkinly Approval Risk and High-Value 2026 Pipeline Catalysts Support Buy Rating
1M ago
GMAB
Truist maintains optimism for 2026 read-out after Genmab’s Phase 3 trial OS miss
Premium
The Fly
Truist maintains optimism for 2026 read-out after Genmab’s Phase 3 trial OS miss
1M ago
GMAB
AbbVie announces results for epcoritamab from Phase 3 EPCORE DLBCL-1 trial
Premium
The Fly
AbbVie announces results for epcoritamab from Phase 3 EPCORE DLBCL-1 trial
1M ago
ABBV
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >